SRL
AKBA icon

Scientech Research LLC’s Akebia Therapeutics AKBA Stock Holding History

Scientech Research LLC’s Portfolio AKBA Stock Details AKBA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$40.1K Buy
+35,190
New +$41.9K 0.03% 202
2025
Q2 		– Sell
-10,510
Closed -$20.2K – 581
2025
Q1 		$20.2K Buy
+10,510
New +$21.5K 0.01% 531

Other funds holding AKBA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Scientech Research LLC's AKBA Position: Q2 2026 in Review

Scientech Research LLC opened a new position in Akebia Therapeutics (AKBA) in Q2 2026: 35,190 shares worth $40.1K. The stake represents 0.03% of the portfolio and ranks #202 among its holdings. This is a return to the name: Scientech Research LLC previously reported a position in AKBA as recently as Q1 2025.

Scientech Research LLC first reported a position in AKBA in Q1 2025 and has held it in 2 quarters since. 171 funds tracked by Wall St. Rank hold AKBA as of Q2 2026.

  • Scientech Research LLC held 35,190 shares of Akebia Therapeutics worth $40.1K as of Q2 2026.
  • Akebia Therapeutics was a new Scientech Research LLC position in Q2 2026.
  • Akebia Therapeutics made up 0.03% of Scientech Research LLC's portfolio in Q2 2026, its #202 holding.
  • Scientech Research LLC first reported a position in Akebia Therapeutics in Q1 2025 and has held it in 2 quarters since.
  • 171 funds tracked by Wall St. Rank held Akebia Therapeutics as of Q2 2026.

Based on Scientech Research LLC's 13F filing for Q2 2026, filed 14 Aug 2026.